CRESPONSE Trademark

Trademark Overview

On Monday, May 20, 2024, a trademark application was filed for CRESPONSE with the United States Patent and Trademark Office. The USPTO has given the CRESPONSE trademark a serial number of 98560183. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 12, 2025. This trademark is owned by Curesponse Ltd.. The CRESPONSE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic testing materials, namely, specialized biological tissue culture for medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use, namely cancer research; biological tissue cultures for medical purposes

Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer; providing medical testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes

Laboratory testing of materials in the nature of analysis in the field of cancer testing and pathology; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation
cresponse

General Information

Serial Number98560183
Word MarkCRESPONSE
Filing DateMonday, May 20, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, March 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

Goods and ServicesDiagnostic testing materials, namely, specialized biological tissue culture for medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use, namely cancer research; biological tissue cultures for medical purposes
Pseudo MarkC RESPONSE
Goods and ServicesMedical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer; providing medical testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes
Goods and ServicesLaboratory testing of materials in the nature of analysis in the field of cancer testing and pathology; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 20, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 20, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCuresponse Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTel Aviv 6423906
IL

Trademark Events

Event DateEvent Description
Tuesday, May 21, 2024NEW APPLICATION ENTERED
Saturday, November 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 4, 2024ASSIGNED TO EXAMINER
Monday, December 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NON-FINAL ACTION WRITTEN
Monday, December 23, 2024NON-FINAL ACTION WRITTEN
Monday, February 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

cresponse medical diagnostic purposes cancer testing treatment services tissue pharmaceutical field